2023 - DPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development
Date2023-10-13
Deadline2023-10-13
VenueWebinar, USA - United States
KeywordsClinical Research; CRO; Genomics
Topics/Call fo Papers
Regulated digital polymerase chain reaction (dPCR), quantitative polymerase chain reaction (qPCR) and reverse transcriptase quantitative polymerase chain reaction (qRT-PCR) are extensively utilized to support biodistribution, vector shedding, gene expression, chimeric antigen receptor (CAR) T cell therapy and oncolytic viral bioanalytical studies.
In this presentation, the featured speakers will review the advantages and disadvantages of dPCR, qPCR and qRT-PCR as it relates to vaccine and biotherapeutic research. They will also discuss the current method development and method validation best practices, context of use and level of regulatory compliance required to support bioanalysis in pre-clinical and clinical settings.
Join this informative webinar to gain insights into the best use of PCR methods in vaccine and biotherapeutic research in pre-clinical and clinical development.
In this presentation, the featured speakers will review the advantages and disadvantages of dPCR, qPCR and qRT-PCR as it relates to vaccine and biotherapeutic research. They will also discuss the current method development and method validation best practices, context of use and level of regulatory compliance required to support bioanalysis in pre-clinical and clinical settings.
Join this informative webinar to gain insights into the best use of PCR methods in vaccine and biotherapeutic research in pre-clinical and clinical development.
Other CFPs
- Advances in oncological imaging: Tumour growth rate modelling and radiomics
- Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products
- Patient-Centric Clinical Trials: Strategies for Accelerated Enrollment, Data Insights and Trial Success
- Experiences with a Rapid Multiplex NAT System for Bloodstream Infections at a Tertiary Cancer Center
- Updates in Cell and Gene Therapy with a Focus on Kidney Disease and Operational Considerations
Last modified: 2023-08-28 23:54:27